Unlike EGFR levels, which are upregulated at baseline in BRAFV600E cell lines12,13, comparison of untreated primary patient colorectal tumor specimens harboring or not harboring a BRAFV600E mutation showed that patient tumors start with similar levels of total SRC (Extended Data Fig. 1d). This evidence concerns the gene EGFR and colorectal neoplasm.